Course Hero Logo

Study concept and design acquisition of data analysis

Course Hero uses AI to attempt to automatically extract content from documents to surface to you and others so you can study better, e.g., in search results, to enrich docs, and more. This preview shows page 13 - 14 out of 14 pages.

Study concept and design, acquisition of data,analysis and interpretation of data, drafting of themanuscript, critical revision of the manuscript forimportant intellectual content, administrative,technical, and material support,andstudysupervision:All authors.Conflict of Interest Disclosures:All authors havecompleted and submitted the ICMJE Form forDisclosure of Potential Conflicts of Interest. DrOparil reports individual and institutional paymentrelated to board membership from Bayer, DaiichiSankyo, Novartis, Medtronic, and Takeda; individualconsulting fees from Backbeat, Bayer,Boehringer-Ingelheim, Bristol Myers-Squibb, DaiichiSankyo, Eli Lilly, Medtronic, Merck, Pfizer, andTakeda; receipt of institutional grant funding fromAstraZeneca, Daiichi Sankyo, Eisai Inc, Gilead,Medtronic, Merck, Novartis, Takeda GlobalResearch and Development Inc; individual paymentfor lectures from Daiichi Sankyo, Merck, Novartis,and Pfizer; individual and institutional payment fordevelopment of educational presentations fromASH/AHSR (Daiichi Sankyo); and individual andinstitutional payment from Amarin Pharma Inc,Daiichi Sankyo, and LipoScience Inc for educationalgrant(s) for the Annual UAB Vascular Biology &Hypertension Symposium. Dr Cushman reportsreceipt of institutional grant support from Merck,Lilly, and Novartis; and consulting fees fromNovartis, Sciele Pharmaceuticals, Takeda,sanofi-aventis, Gilead, Calpis, Pharmacopeia,Theravance, Daiichi-Sankyo, Noven, AstraZenecaSpain, Merck, Omron, and Janssen. Dr Townsendreports board membership with Medtronic,consultancy for Janssen, GlaxoSmithKline, andMerck, and royalties/educational-related paymentsfrom Merck, UpToDate, and Medscape. Dr Wrightreports receipt of consulting fees from Medtronic,CVRx, Takeda, Daiichi-Sankyo, Pfizer, Novartis, andTake Care Health. The other authors report nodisclosures.Funding/Support:The evidence review for thisproject was funded by the National Heart, Lung,and Blood Institute (NHLBI).Role of the Sponsor:The design and conduct ofthe study; collection, management, analysis, andinterpretation of the data; preparation, review, andapproval of the manuscript; and decision to submitthe manuscript for publication are theresponsibilities of the authors alone andindependent of NHLBI.Disclaimer:The views expressed do not representthose of the NHLBI, the National Institute ofDiabetes and Digestive and Kidney Diseases, theNational Institutes of Health, or the federalgovernment.Additional Contributions:We thank Cory V. Evans,MPP, who at the time of the project was a seniorresearch analyst and contract lead for JNC 8 withLeidos (formerly Science Applications InternationalCorporation) and Linda J. Lux, MPA, RTIInternational, for their support. We also thankLawrence J. Fine, MD, DrPH, NHLBI, for his workwith the panel. Those named here werecompensated in their roles as consultants on theproject.

Upload your study docs or become a

Course Hero member to access this document

End of preview. Want to read all 14 pages?

Upload your study docs or become a

Course Hero member to access this document

Term
Fall
Professor
N/A
Tags
Diabetes, Test, RCT, evidence review

Newly uploaded documents

Show More

Newly uploaded documents

Show More

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture